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abstract
 
Ether à go-go (Eag; K
 
V
 
10.1) voltage-gated K
 
 
 
 channels have been detected in cancer cell lines of
diverse origin and shown to inﬂuence their rate of proliferation. The tricyclic antidepressant imipramine and the
antihistamine astemizole inhibit the current through Eag1 channels and reduce the proliferation of cancer cells.
Here we describe the mechanism by which both drugs block human Eag1 (hEag1) channels. Even if both drugs
differ in their afﬁnity for hEag1 channels (IC
 
50
 
s are 
 
 
 
2 
 
 
 
M for imipramine and 
 
 
 
200 nM for astemizole) and in
their blocking kinetics, both drugs permeate the membrane and inhibit the hEag1 current by selectively binding
to open channels. Furthermore, both drugs are weak bases and the IC
 
50
 
s depend on both internal an external pH,
suggesting that both substances cross the membrane in their uncharged form and act from inside the cell in their
charged forms. Accordingly, the block by imipramine is voltage dependent and antagonized by intracellular TEA,
consistent with imipramine binding in its charged form to a site located close to the inner end of the selectivity ﬁlter.
Using inside- and outside-out patch recordings, we found that a permanently charged, quaternary derivative of
imipramine (
 
N
 
-methyl-imipramine) only blocks channels from the intracellular side of the membrane. In contrast,
the block by astemizole is voltage independent. However, as astemizole competes with imipramine and intracellular
TEA for binding to the channel, it is proposed to interact with an overlapping intracellular binding site. The
signiﬁcance of these ﬁndings, in the context of structure–function of channels of the 
 
eag
 
 family is discussed.
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INTRODUCTION
 
Ether à go-go 1 (Eag1) channels (K
 
V
 
10.1; Catterall et
al., 2002) are transmembrane proteins belonging to
the family of voltage-gated K
 
 
 
 channels (Warmke et al.,
1991; Brüggemann et al., 1993; Ludwig et al., 1994;
Warmke and Ganetzky, 1994). In adult mammals, the
expression of Eag1 channels is restricted to the nervous
system (Ludwig et al., 1994; Occhiodoro et al., 1998;
Shi et al., 1998; Pardo et al., 1999; Ludwig et al., 2000;
Saganich et al., 2001). However, Eag1 channels are also
ectopically expressed in many cancer cell lines and are
thought to be important for tumor growth (Meyer and
Heinemann, 1998; Meyer et al., 1999; Pardo et al.,
1999; Ouadid-Ahidouch et al., 2001; Gavrilova-Ruch et
al., 2002).
In particular, transfection of Eag1 into mammalian
cells confers a transformed phenotype and favors tumor
progression in vivo, while inhibition of Eag1 expression
inhibits cell proliferation (Pardo et al., 1999). The
molecular mechanisms responsible for this phenome-
non are unknown. Interestingly, it has recently been
published that, when present in the growth medium
of Eag1-expressing tumor cells, both the tricyclic anti-
depressant imipramine (Gavrilova-Ruch et al., 2002)
and the antihistamine astemizole (Ouadid-Ahidouch
et al., 2001) slow cell proliferation. This effect was
proposed to result from the selective blockade of Eag1
channels by both drugs. Therefore, knowledge about
the mechanism of block of Eag1 channels by these
substances should facilitate the analysis of the role these
channels play in cell cycle regulation. Experimental
evidence is presented here that gives insight into a
common mode of action for these drugs, and the sig-
niﬁcance of these ﬁndings, in the context of structure–
function of channels of the 
 
eag
 
 family, is discussed.
 
MATERIALS AND METHODS
 
Human ether à go-go 1 channels (hEag1; Occhiodoro et al.,
1998; Pardo et al., 1999) cloned into pTracer-CMV (Invitrogen)
were stably expressed in HEK-293 cells (human embryonic kidney;
DSMZ). Cells were grown in DMEM/nutrient mixture F-12 with
glutamax-I (GIBCO BRL) supplemented with 10% fetal calf serum
and Zeocin (300 
 
 
 
g/ml).
For electrophysiological experiments, cells were grown for 24–
72 h on poly-
 
l
 
-lysine–coated glass coverslips. All electrophys-
iological experiments were performed at room temperature.
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 QA, quaternary ammonium. 
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Macroscopic currents were recorded in the whole-cell, inside-
out, or outside-out conﬁgurations of the patch-clamp technique
(Hamill et al., 1981) using an EPC-9 ampliﬁer (HEKA). Patch pi-
pettes with a tip resistance of 0.9–1.5 M
 
 
 
 were made from Corn-
ing #0010 capillary glass (WPI). Series resistance was com-
pensated by 
 
 
 
60%. The control internal solution contained (in
mM) 100 KCl, 45 NMDG, 10 1,2-bis(2-aminophenoxy)ethane-
 
N
 
,
 
N
 
,
 
N
 
 
 
,
 
N
 
 
 
-tetraacetic acid tetrapotassium salt (BAPTA·K
 
4
 
), 10
HEPES/HCl, pH 7.35. In experiments where the pH of the inter-
nal solution was set to 6.4 or 8.4 (Figs. 8 and 9), HEPES was re-
placed with an equivalent concentration of MES or CHES, re-
spectively. The control external recording solution contained (in
mM) 160 NaCl, 2.5 KCl, 2 CaCl
 
2
 
, 1 MgCl
 
2
 
, 8 glucose, 10 HEPES/
NaOH, pH 7.4. In experiments where the pH of the external so-
lution was set to 6.4 or 8.4 (Figs. 8 and 9), HEPES was replaced
with an equivalent concentration of BIS-TRIS propane. In exper-
iments using high external [K
 
 
 
], [Na
 
 
 
] was lowered so that the
sum of [K
 
 
 
] and [Na
 
 
 
] remained constant. Cell-attached patches
(Fig. 4) were recorded using 140 mM external K
 
 
 
 and a pipette
solution containing control external recording solution without
glucose. Inside-out patches (Figs. 9 and 10) were recorded using
a pipette solution containing (in mM) 145 NaCl, 5 KCl, 3 CaCl
 
2
 
,
1 MgCl
 
2
 
, 10 HEPES/NaOH, pH 7.4, and a bath solution contain-
ing (in mM) 160 KCl, 0.5 MgCl
 
2
 
, 10 EGTA, 10 BIS-TRIS pro-
pane/KOH, pH 6.0–8.4.
 
N
 
-methyl-imipramine (Fig. 10) was synthesized from imipra-
mine as follows. 10 ml of a 1.26 M NaOH solution was slowly
added to 20 ml of a 394 mM imipramine hydrochloride solution
cooled to 0
 
 
 
C. The resulting mixture was stirred for 30 min at
this temperature. Then, saturated aqueous solutions of NaCl (50
ml) and CH
 
2
 
Cl
 
2
 
 (50 ml) were added and the aqueous layer was
extracted with CH
 
2
 
Cl
 
2
 
 (3 
 
  
 
50 ml). The combined organic layers
were dried (MgSO
 
4
 
) and evaporated to dryness to provide a yel-
low oil. The oil was dissolved in acetone (10 ml), and 540 
 
 
 
l of
CH
 
3
 
I (2.28 g/ml) was added dropwise under an atmosphere of
argon. After stirring for 2 h at room temperature, the solvent was
removed in vacuo, and the resulting crude product was washed
with acetone. Drying under vacuum provided 
 
N
 
-methyl-imip-
ramine iodide as a white powder (2.95 g, 89%), which was sub-
jected to NMR spectroscopy. The obtained spectra matched the
simulated spectra of 
 
N
 
-methyl-imipramine iodide (Shayman and
Barcelon, 1990).
Figure 1. Concentration dependence of hEag1 block
by imipramine and astemizole. (A and C) Superimposed
hEag1 current traces recorded during 1.5 s test depolar-
izations to 80 mV from a holding potential of  70 mV in
the absence and presence of the indicated concentra-
tions of imipramine (Imi, A) or astemizole (Ast, C). Test
potential was chosen to achieve the maximal open
probability of hEag1, whose activation curve saturates
above 60 mV (not depicted). The effects of drug applica-
tion were monitored with test pulses applied every 30 s
until a steady-state block was reached. (B and D) Current
traces in the presence of imipramine or astemizole were
normalized dividing them point by point by the respec-
tive preapplication traces. Solid lines indicate the best ﬁt
to a single exponential function. (E) Dose–response
plots for imipramine (open circles) and astemizole
(closed circles). The steady-state fraction of channels
blocked was calculated from the asymptotic values of
single exponential ﬁts to current ratios as shown in B
and D. Solid lines represent ﬁts to the data using the Hill
equation, with IC50 values and Hill coefﬁcients of
1.87   M and 1.04 for imipramine, and 0.21  M and
1.32 for astemizole, respectively. (D) Time constant of
block ( block) for imipramine (open circles) and astemi-
zole (closed circles) derived from the least-squares ﬁts
of single exponential functions used in E. Solid lines
represent ﬁts to the data using the Hill equations, with
maximum, minimum, IC50, and Hill coefﬁcients of
86.7 ms, 11.6 ms, 3.75  M, and 1.27 for imipramine,
and 1.33 s, 0.024 s, 0.26  M, and 1.32 for astemizole,
respectively. (G) The rate of current block is repre-
sented ( block
 1) as a linear function of nonsaturating
imipramine (open circles) or astemizole (closed circles)
concentrations. Solid lines represent ﬁts to the data with
a linear function, with slope and y intercept of 2.5
s 1 M 1 and 11.1  M for imipramine, and 4 s 1 M 1
and 0.4  M for astemizole, respectively. The range of
drug concentrations used to ﬁt  block
 1 data to the linear
function was between 0.5 and 10  M for imipramine
and between 25 nM and 5  M for astemizole. Symbols
and associated error bars in E–G represent means  
SEM for six and seven cells for imipramine and astemi-
zole, respectively. 
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Astemizole and 
 
N
 
-methyl-imipramine were diluted from a
DMSO stock solution. The ﬁnal concentration of DMSO was al-
ways 0.1%, a concentration that showed no discernible effects on
hEag1 currents (
 
n
 
 
 
 
 
 4). Imipramine was used from stocks in dis-
tilled water. Both drugs were purchased from Sigma-Aldrich.
Data processing and curve ﬁtting were performed with Igor
Pro (WaveMetrics). Where used, statistical signiﬁcance of the dif-
ference between two groups of data was analyzed with Excel us-
ing Student’s 
 
t
 
 test for a two-tailed distribution of samples with
unequal variance. All quantitative data in the text are expressed
as mean 
 
 
 
 SD.
 
RESULTS
 
Dose-dependent Inhibition of hEag1 Currents by Imipramine 
and Astemizole
 
hEag1 channels do not inactivate during sustained de-
polarizations to potentials that activate most of the
channels (Fig. 1 A, control trace). However, in the pres-
ence of imipramine (Fig. 1 A) or astemizole (Fig. 1 C),
a clear time- and dose-dependent decay of hEag1 cur-
rents was observed. This suggests that both drugs block
open hEag1 channels (Armstrong, 1969). After both
drugs attained the equilibrium concentration near their
active site, consecutive current traces recorded at 30-s
intervals were identical (unpublished data). Thus, there
is no trapping of imipramine and astemizole by closure
of hEag1 channels (Armstrong, 1971; Choquet and
Korn, 1992; Mitcheson et al., 2000a).
The time course of the block induced by both drugs
(I
 
Drug
 
/I
 
Control
 
) followed a single exponential function
at all concentrations tested (Fig. 1, B and D). The re-
spective I
 
Drug
 
/I
 
Control
 
 traces start at values close to one
for nonsaturating drug concentrations, indicating that
channel block proceeds after channel opening. Dose–
response curves constructed from the asymptotic values
of mono-exponential ﬁts to I
 
Drug
 
/I
 
Control
 
 traces gave IC
 
50
 
values of 1.8 
 
 
 
 0.2 
 
 
 
M (
 
n
 
 
 
 
 
 6) for imipramine, and
196 
 
 
 
 36 nM (
 
n
 
 
 
 
 
 7) for astemizole (Fig. 1 E). At these
concentrations, the time constant of current decay
(
 
 
 
block
 
) was 
 
 
 
50 ms for imipramine and 
 
 
 
500 ms for
astemizole (Fig. 1 F).
The linear relationship between the rate of channel
block (
 
 
 
block
 
 
 
1
 
) and nonsaturating drug concentrations
(Fig. 1 G) suggests the following bimolecular reaction:
where 
 
D
 
 represents drug molecules and 
 
C
 
, 
 
O
 
, and 
 
OD
 
denote the closed, open, and blocked states of the
channels, respectively. When 
 
k
 
on
 
[D] 
 
 
 
 
 
 
 
, drug binding
is rate limiting the overall reaction. In such cases,
(SCHEME 1)
Figure 2. Deactivation kinetics in the presence of imi-
pramine and astemizole. (A–C) Superimposed tail current
traces recorded at potentials between  140 and 0 mV after
330-ms depolarizations to 80 mV from a holding potential
of  60 mV in the absence of drugs (A), and in the presence
of 10  M imipramine (B) and 1  M astemizole (C). All
traces were recorded consecutively from the same cell. (D)
Scaled tail current traces from A–C recorded at  60 mV.
(E) Average time constant of a single exponential ﬁt to the
decay phase of the tail current ( close) recorded in control
conditions (open circles), 10  M imipramine (closed
triangles), and 1  M astemizole (inverted closed triangles).
Solid lines represent ﬁts to the data with an arbitrary expo-
nential function:  close(V)         (0) e kV, with    ,  (0),
and k values of 0.75 ms, 15.87 ms, and  0.027 (control);
1.52 ms, 65.13 ms, and  0.039 (imipramine); and 0.75 ms,
10.75 ms, and  0.025 (astemizole), respectively. Symbols
and associated error bars represent means   SEM for
ﬁve cells.304 Open-channel Block of hEag1 Channels
(1)
The association (kon) and dissociation (koff) constants,
obtained from the linear regions in Fig. 1 G, are
2.5   M 1s 1 and 11.1 s 1 for imipramine, and 4.0
 M 1s 1 and 0.4 s 1 for astemizole. These rate con-
stants give KD values (koff/kon) of 4.7  M for imip-
ramine and 109 nM for astemizole, in good agree-
ment with IC50 values calculated from dose–response
curves. Thus, the main difference between both drugs
is the long half-life of astemizole at its binding site in
hEag1 channels.
Channel activation becomes rate limiting for the
overall reaction in Scheme I at saturating drug concen-
trations, where kon[D]       (French and Shoukimas,
1981; Kuo, 1998). Consequently, at these drug concen-
trations, IDrug/IControl traces start at values well below
one (Fig. 1, B and D), and the experimental data
points for the observed macroscopic binding rate fall
below the respective regression lines in Fig. 1 G.
τblock
 1 kon D [] koff. + =
Effects of Imipramine and Astemizole on hEag1 
Closing Kinetics
Scheme I implies that imipramine and astemizole need
to unbind before hEag1 channels can close. The analy-
sis of tail currents recorded in high external [K ] sup-
ports this hypothesis for imipramine. hEag1 currents
deactivate through a mono-exponential time course in
control conditions (Fig. 2 A). However, in the presence
of imipramine, tail currents showed a transient in-
crease before deactivating (Fig. 2, B and D). This indi-
cates that imipramine unbinding is faster than channel
closing (Armstrong, 1969). Deactivation was slowed in
the presence of imipramine (Fig. 2 E), suggesting that
its binding interferes with the channels’ closing gate, a
phenomenon that has been termed “foot-in-the-door”
effect (Yeh and Armstrong, 1978).
In contrast, tail currents recorded in the presence of
astemizole were a scaled-down version of the control
trace (Fig. 2, C and D), indicating that only unblocked
channels contribute to macroscopic tail currents. At
Figure 3. Inﬂuence of high extracellular K  on the recovery from imipramine and astemizole block. (A) Recovery of hEag1 at  70 mV
from block by 10  M imipramine with 2.5 (left) or 140 mM external K  (right) is demonstrated using two depolarizations to 100 mV from
a holding potential of  70 mV separated by an interval of variable duration. The ﬁrst depolarization is 500 ms long, and the ﬁrst 100 ms
from the second depolarization is shown. (B) Time course of recovery from imipramine block in low (open circles) and high extracellular
[K ] (closed circles). The fraction of channels that have recovered by the time of the second depolarization (Fraction Recovered) is
calculated as: Fraction Recovered   (I2   ISS)/(I1   ISS), where I1 and I2 represent peak current during the ﬁrst and second pulse,
respectively, and ISS represents the sustained current at the end of the ﬁrst pulse. The solid lines are single exponential ﬁts with time
constants and asymptotic values of 8.7 ms and 1.45, and 23.7 ms and 1.3 for 2.5 and 140 mM external K , respectively. (C) Recovery of
hEag1 at  70 mV from block by 2  M astemizole in low (left) or high (right) concentrations of external K . Two depolarizations to 80 mV
from a holding potential of  70 mV were applied separated by a variable interval. The ﬁrst depolarization is 1 s long, and the ﬁrst 250 ms
from the second depolarization is shown. (D) Time course of recovery from astemizole block in low (open circles) and high extracellular
K  (closed circles). Fraction of channels recovered was calculated as in B. The solid lines are single exponential ﬁts with time constants of
5.8 and 3.2 s, for 2.5 and 140 mM external K , respectively.305 García-Ferreiro et al.
saturating astemizole concentrations, tail currents were
completely absent (unpublished data). This can be ac-
counted for by the small koff derived in Fig. 1 G for the
astemizole–hEag1 interaction.
Time Course of the Recovery from Block
To further analyze the unbinding of imipramine and
astemizole from hEag1 channels, and to assess the effect
of K  on this process, we used a double-pulse protocol
in which two identical test pulses were separated by an
interval of variable duration. In these conditions, hEag1
channels recovered from imipramine (Fig. 3 A) and
astemizole block (Fig. 3 C) following a mono-exponen-
tial time course. Drug trapping by channel closing was
not observed even at a recovery potential of  120 mV
(unpublished data). The time constant of recovery at
 70 mV was 24   1 ms (n   5) for imipramine and
6.14   1.57 s (n   6) for astemizole.
koff depends on the driving force for K  ions for block-
ers that occlude the permeation pathway (Armstrong,
1966). A 56-fold increase in the extracellular [K ] did
not result in any obvious alteration in the rate of cur-
rent block at depolarized potentials (unpublished data).
However, high external [K ] accelerated the recovery of
hEag1 channels from imipramine block by 63.1   3.1%
(n   5), and by 43.9   8.0% (n   6) from that by astem-
izole (Fig. 3, B and D). The time constant of recovery at
 70 mV recorded in the presence of 140 mM external
K  was 8.8   0.5 ms (n   5) for imipramine and 3.52  
1.27 s (n   6) for astemizole. The simplest interpreta-
tion for this effect is that the inﬂux of K  ions during re-
polarization is relieving occlusion by internal blockers
(Armstrong, 1966, 1971; Demo and Yellen, 1991; Choi
et al., 1993; DeCoursey, 1995). This suggests that both
drugs are binding to the permeation pathway of hEag1
channels entering from its intracellular side. This re-
quires them to permeate through the membrane, given
that both drugs were applied to the bath.
During recovery from imipramine block, the peak
current elicited by the second pulse transiently sur-
passed that elicited by the ﬁrst pulse (Fig. 3, A and B).
This “overshoot” seems to result from the faster activa-
tion of the current during the second pulse, which
causes more channels to accumulate in the open state
before they are blocked. The current activates faster
because, ﬁrst, imipramine slows current deactivation
(Fig. 2), and thus some channels are still open at short
intervals after the ﬁrst pulse. Second, the activation ki-
netics of Eag1 channels depends on the prepulse po-
tential (Terlau et al., 1996). Thus, the activation kinet-
ics of the ﬁrst test pulse current are slow due to the
negative holding potential ( 70 mV), while that of the
second are accelerated by the previous depolarization.
Accordingly, the overshoot was reduced for depolar-
ized holding potentials ( 50 mV) and augmented for
more hyperpolarized holding potentials ( 90 mV; un-
published data).
Imipramine and Astemizole are Membrane Permeant
The ability of imipramine and astemizole to perme-
ate the membrane was investigated using cell-attached
patches (Fig. 4). In this conﬁguration, drugs can only
access the channels contained in the patch by passing
through the membrane. hEag1 channels recorded in
these conditions were blocked by bath applications of
imipramine (Fig. 4 A) and astemizole (Fig. 4 B). This
experiment, however, does not exclude an extracellular
site of action for imipramine and/or astemizole (Brock
et al., 2001). To determine the sidedness of the block
by these drugs, we tested for competition with TEA.
This cation is an open-pore blocker of voltage-gated K 
channels (Armstrong, 1966, 1969, 1971). K  channels
have two binding sites for TEA located at the intra- and
extracellular ends of the selectivity ﬁlter (MacKinnon
and Yellen, 1990; Yellen et al., 1991). Since it is per-
manently charged, TEA is virtually membrane imper-
Figure 4. Membrane permeability of imipramine and astemizole. Superimposed hEag1 current traces recorded during 1-s depolarizations
to 60 mV from a holding potential of  70 mV in the absence, presence, and after washout of the indicated bath concentrations of
imipramine (A) or astemizole (B) in cell-attached patches.306 Open-channel Block of hEag1 Channels
meant and can be conﬁned to either side of the mem-
brane by inclusion in the bath or pipette solutions (for
review see Stanﬁeld, 1983).
TEA blocks  50% of the hEag1 current at 80 mV
when present at 7 mM in the external solution or 200
 M in the internal solution (unpublished data). While
7 mM external TEA did not affect the block by imip-
ramine or astemizole (Fig. 5, A–F), both drugs showed
a  50% reduced potency in the presence of 200  M in-
ternal TEA (Fig. 5, A and B). While 10  M imipramine
blocked 77   2% (n   5) of the control current, it only
blocked 39   3% (n   5; P   10 7) of the current in
the presence of internal TEA (Fig. 5 E). On the other
hand, 1  M astemizole blocked 87   3% of the control
current (n   5) and only 42   12% of the current re-
corded in the presence of internal TEA (n   5; P  
10 5). The time course of block by both drugs was ap-
proximately two times slower with internal TEA than in
the control (Fig. 5 F).  block for imipramine was in-
creased from 35   4 ms in the control to 86   5 ms
with internal TEA (P   10 6), and that for astemizole
was increased from 317   73 ms to 1084   158 ms (P  
0.005) in the same conditions. The simplest interpreta-
tion of these results is that imipramine and astemizole
compete with internal TEA for overlapping binding
sites (Choi et al., 1991). This strongly suggests that the
binding sites for imipramine and astemizole are lo-
cated in the intracellular portion of the permeation
pathway of hEag1 channels.
The fact that both drugs compete for binding with
internal TEA suggests that both drug binding sites
overlap. We tested for competition between imipra-
mine and astemizole (Fig. 6). While 100 nM astem-
izole blocked 66   3% (n   5) of the control current,
this concentration of the drug blocked 38   5% (n  
5; P   0.002) of the current in the presence of 5  M
imipramine (Fig. 6 C). As in the case of internal TEA,
the simplest interpretation of this result is that both
drugs compete for overlapping binding sites in hEag1
channels.
Voltage Dependence of Imipramine– and Astemizole–hEag1 
Interactions
Imipramine and astemizole are both weak bases pre-
dicted to be protonated most of the time (99 and 93%,
respectively) in our standard, pH 7.4 recording solu-
tion. If they bind to hEag1 channels in their charged
form, and their binding sites lie deep in the mem-
Figure 5. Competition of imipramine and astemizole
with internal TEA. (A and B) Superimposed hEag1 current
traces recorded during 1-s (A) or 1.5-s (B) depolarizations
to 80 mV from a holding potential of  70 mV. The indicated
concentrations of imipramine (A) or astemizole (B) were
applied in control conditions (left), in the presence of 7 mM
TEA in the external solution (TEAe; middle), or in the
presence of 200  M TEA in the internal solution (TEAi;
right). Both external and internal concentrations of TEA 
were chosen to achieve  50% of current block by this
cation. (C and D) Current traces in the presence of imip-
ramine (A) or astemizole (B) were normalized dividing
them point by point by the respective preapplication traces.
Solid traces through the points indicate the best ﬁt to a
single exponential function. (E) Steady-state fraction of
channels blocked was calculated from the asymptotic values
of single exponential functions ﬁt to current ratios as shown
in C and D. (F) Time constant of block ( block) derived from
the least-squares ﬁts of single exponentials used in E.
Columns and associated error bars in E and F represent
means   SEM for ﬁve cells recorded in control conditions
(open columns), and in the presence of external TEA
(closed columns), and ﬁve cells recorded in the presence of
internal TEA (hatched columns).307 García-Ferreiro et al.
brane, their binding would be affected by a fraction
of the potential difference across the membrane (Wood-
hull, 1973). Thus, to further characterize the binding
site of both drugs, we investigated if their binding afﬁn-
ity is affected by membrane potential.
The fraction of blocked current by a constant con-
centration of imipramine increases with increasing de-
polarization of the membrane potential (Fig. 7 A). In
particular, the IC50 decreased as an exponential func-
tion of test pulse potential (Fig. 7 E). This variation can
be well described with the single exponential function
(2)
where z represents the valence of the blocker, and  
reﬂects the fraction of the electric ﬁeld across the
membrane that is sensed by the blocker (Woodhull,
1973). Given that imipramine has a single protona-
tion site (z   1), it is estimated from these results to
sense 39% of the membrane electric ﬁeld at its bind-
ing site (Fig. 7 E).
In contrast to imipramine, the block induced by a
constant concentration of astemizole is insensitive to
membrane potential at voltages  60 mV (Fig. 7 C),
where hEag1 open probability is  60% (Fig. 7 E). This
ﬁnding suggests either (a) that astemizole blocks hEag1
channels by binding in its uncharged form or (b) that
the binding site lies out of the major drop of transmem-
brane potential.
IC50 V () IC50 0 () e
 zδF
RT
--------------V
, =
Imipramine and Astemizole Block hEag1 Channels in their 
Charged Form
The binding afﬁnity of a base that blocks in its charged
form should increase with increasing acidity of the so-
lution surrounding the binding site, and the opposite
should happen if the active form is uncharged (Albert,
1952). Thus, to conﬁrm that the blocking moiety of im-
ipramine is the charged one, and to determine the ac-
tive form of astemizole, we assessed the effect of pH
variations on the binding afﬁnity of both drugs.
Variations in both intra- and extracellular pH (pHint,
pHext) inﬂuence hEag1 behavior. Exposure of inside-out
patches to pHint 6.4 resulted in an  63% reduction
(compared with the values at pHint 7.4) of the current re-
corded at 100 mV, while pHint 8.4 increased current am-
plitude by 32% (see Fig. 9 E). These changes seem to
result from the block of hEag1 channels by protons
(Starkus et al., 2003), since no obvious changes in the ac-
tivation threshold of the current could be detected.
Whole-cell currents recorded at pHint 6.4 started to acti-
vate at the same potentials as control (  40 mV), but
showed current rectiﬁcation at potentials positive to 80
mV (unpublished data). In contrast, changes in pHext
shifted the voltage dependence of hEag1 currents (Ter-
lau et al., 1996). Compared with the values at pHext 7.4,
pHext 6.4 shifted the activation  15 mV in the depolariz-
ing direction, while pHext 8.4 slightly shifted the activa-
tion by  3 to  5 mV. In consequence, currents re-
corded at 80 mV were  22% reduced at pHext 6.4, and
Figure 6. Competition of imip-
ramine and astemizole for overlap-
ping binding sites. (A) Superim-
posed hEag1 current traces recorded
during 5-s depolarizations to 60 mV
from a holding potential of  70 mV
in the absence (top) and presence
(bottom) of 100 nM astemizole, in
control external solution (left) or in
external solutions containing 2.5
(center) or 5  M (right) imip-
ramine. (B) Current traces in the
presence of astemizole from A were
normalized by a point-wise division
by the respective preapplication
control trace. (C) The steady-state
fraction of channels blocked was
calculated from the asymptotic values
of single exponential functions ﬁt to
the respective current ratios, as
shown in B. (D) Single time con-
stant ( block) of exponential ﬁts used
in C. Columns and associated er-
ror bars in C and D represent the
means   SEM for ﬁve cells tested in
control conditions (open columns),
and in the presence of 2.5 (closed
columns) or 5  M imipramine
(hatched columns).308 Open-channel Block of hEag1 Channels
 2% increased at pHext 8.4, compared with control
pHext (unpublished data). Similar changes induced by
pHext variations have been explained in terms of changes
in the transmembrane potential sensed by the channels
due to titration by protons of negative charges at the
membrane surface (for review see McLaughlin, 1989).
Whole-cell currents were more inhibited by bath ap-
plications of imipramine as pHext was made more alka-
line (Fig. 8 B) or pHint was made more acidic (Fig. 8 C).
Similar IC50 values are recorded at pHext//pHint 8.4//
7.35 (364   62 nM) and 7.4//6.4 (395   61 nM), or
when this relation is 6.4//7.35 (19.2   1.4  M) and
7.4//8.4 (9.8   0.6  M; Fig. 8 D). Therefore, the effec-
tiveness of imipramine does not depend primarily on
either pHext or pHint but rather on their algebraic dif-
ference. Changes in the rate of current block by imi-
pramine at different pHint can be fully accounted for by
changes in kon[D] (Eq. 1), without any detectable
change in koff (Fig. 8 E). Thus, variations in the appar-
ent potency of imipramine reﬂect a change in the con-
centration of the active compound close to the binding
site, and not a change in the afﬁnity of the binding site
for the drug.
As imipramine was bath applied, only the concentra-
tion of charged imipramine inside the cell ([imi ]int)
is expected to change with variation in pHext//pHint
(for review see Ariëns and Simonis, 1963; Ritchie and
Greengard, 1966). In our experimental conditions,
[imi ]int is given by
(3)
Given that measurements of Fig. 8 were made at pH   
pKa, and assuming that a constant effect is produced at
a constant [imi ]int, Eq. 3 can be rewritten as (Choquet
and Korn, 1992)
(4)
Fig. 8 F plots (log IC50) as a function of the difference
between pHext and pHint. The best linear ﬁt to the ex-
imi
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Figure 7. Voltage dependence of imipramine and
astemizole block of hEag1 channels. (A and C) Current
traces recorded during 1-s (A) or 3-s (C) depolarizations
to potentials between 0 and 100 mV in the presence of
5  M imipramine (A) or 1  M astemizole (C) were
normalized dividing them point by point by the respec-
tive preapplication control traces at each potential. (B
and D) Dose–response plots for imipramine (B) and
astemizole (D) at membrane potentials of 20 (ﬁlled
circles), 40 (open squares), 60 (ﬁlled squares), 80 (open
upright triangles), 100 (ﬁlled upright triangles), and
120 mV (open inverted triangles). The steady-state
fraction of channels blocked was calculated from the
asymptotic values of single exponential ﬁts to current
ratios, as shown in A and C using test depolarizations of
1 and 1.5 s for imipramine and astemizole, respectively.
The data were ﬁtted using the Hill equation (solid
lines). IC50 values are plotted in E as a function of test
potential. Symbols and associated error bars in B and D
represent mean   SEM for three (0.1, 2, 5, and 50  M)
and ﬁve (0.5 and 5  M) cells for imipramine, and six
(0.1, 1, and 5  M) and nine (0.025 and 0.25  M) cells
for astemizole. (E, left axis) IC50 values derived from A
(open circles) or B (closed circles) plotted as a function
of the test potential. Solid line through imipramine data
represents the ﬁt to the data to Eq. 2, with IC50(0), and
z  values of 4.92  M and  0.39 e0, respectively. Solid
line through astemizole data represents the equation
IC50(V)   0.12  M. (E, right axis) Open probability of
hEag1 channels at the different test potentials (Popen;
open diamonds). Popen was deﬁned as the fractional
tail current recorded after a given test pulse to that
recorded after a test pulse to 160 mV. Isochronal tail
currents were measured at  80 mV, 500  s after the end
of the 50-ms test pulse in an external solution containing
50 mM K  and no Mg2 . Symbols and associated error
bars represent mean   SEM for six cells. Solid line
through Popen data represents the best ﬁt to a Boltzmann
equation with half activation at 13.8 mV.309 García-Ferreiro et al.
perimental values gives a slope of  0.86, in close agree-
ment with the theoretical value of  1 implied in Eq. 4
(drawn as a dotted line in Fig. 8 F). The calculated
[imi ]int required to induce a 50% reduction in the
hEag1 current by this ﬁt is 2.7  M. Therefore, the ob-
served experimental variations in IC50 can be accounted
for by changes in [imi ]int at the different pHext//pHint
combinations employed.
In cases where pHint    pHext, [imi ]int     [imi]tot
(Ariëns and Simonis, 1963; Ritchie and Greengard,
1966). Trapping of charged imipramine in the interior
of the cell can explain that the block washout time
course at constant pHext is slowed as pHint is made more
acidic. A single exponential ﬁt to the fraction of origi-
nal current recovered at pHext 7.4 after  90% inhibi-
tion gave time constants of 6   1, 19   6, and 46   8 s
at pHint of 8.4, 7.4, and 6.4, respectively, in our record-
ing conditions (n   4, 3, 5).
Assuming that the uncharged form of astemizole is
membrane permeant (Fischer et al., 1998), its concen-
tration inside the cell at steady state when applied
externally is expected to remain constant at con-
stant pHext (Ariëns and Simonis, 1963). However, the
block of hEag1 channels by astemizole was affected by
changes in the pHext//pHint relation. IC50 shifted to the
left for pHext   pHint, and to the right for pHext   pHint
(Fig. 9 A). Similar IC50 values were obtained when
pHext//pHint were 8.4//7.35 (37   7 nM) and 7.4//6.4
(54   12 nM), or when this relation was 6.4//7.35 (419  
68 nM) and 7.4//8.4 (556   69 nM; Fig. 9 A). Fig. 9 C
shows the variation in (logIC50) as a function of the dif-
ference between pHext and pHint. The best linear ﬁt to
the experimental values gave a slope of  0.53. This
suggests the following empirical relation
(5)
Fig. 9 D shows the variation in log(IC50)2 as a function
of the difference between pHext and pHint. The best lin-
ear ﬁt to the experimental values gives a slope of
 1.04, in accord with the theoretical value of  1 im-
plied in Eq. 5 (drawn as a dotted line in Fig. 9 D). The
log IC50 ()
2 c pHext pHint – () . – =
Figure 8. pH dependence of imipramine block of hEag1
channels. (A–C) Superimposed whole-cell current traces
recorded during 1-s depolarizations to 80 mV from a holding
potential of  70 mV in the absence (top) and presence
(bottom) of 2.5  M imipramine. Currents were recorded in
control external and internal solutions (A), or in conditions
where either the pH of the external (pHext; B) or internal
solutions (pHint; C) was varied to the indicated values. (D)
Dose–response plots for imipramine at pHext//pHint rela-
tions of 7.4//7.35 (open circles), 6.4//7.35 (closed in-
verted triangles), 8.4//7.35 (closed triangles), 7.4//6.4
(open inverted triangles), and 7.4//8.4 (open upright
triangles). The steady-state fraction of channels blocked was
calculated as in Fig. 1 B. The data were ﬁtted using the Hill
equation (solid lines, see text for average IC50). (E) Rate of
current block ( block
 1) as a function of nonsaturating
imipramine concentrations recorded at pHext 7.4, and pHint
6.4 (open inverted triangles), 7.35 (closed circles), or 8.4
(open triangles). Straight lines through  block
 1 data repre-
sent ﬁts to the data with linear functions with slopes of 12.6,
3.4, and 0.9 s 1 M 1, and y intercepts of 10.4, 10.7, and 10.7
 M to data recorded at pHint 6.4, 7.4, and 8.4, respectively.
Symbols and associated error bars in D and E represent
means   SEM for three (control) and ﬁve cells (rest of
the conditions). (F) logIC50 plotted as a function of the
difference between pHext and pHint. Closed circles and
associated error bars represent means   SD of individual
ﬁts to cells shown in D, plus four cells tested at pHext//pHint
7.1//7.7, ﬁve cells at 7.1//6.8, three cells at 7.6//6.8, and
ﬁve cells at 7.1//8. Straight line through symbols represents
the best ﬁt of a linear function with slope  0.86, and y
intercept 0.43, to the data. The dotted line has the same y
intercept, but a slope of  1.310 Open-channel Block of hEag1 Channels
fact that IC50 varies linearly as function of the pHext//
pHint relation shows that it does not depend primarily
on a certain value of each of them. Therefore, the afﬁn-
ity of the binding site for astemizole in hEag1 channels
can be assumed as constant in the pH 6.4–8.4 range.
Equal effects at different pHint should therefore reﬂect
an equal amount of the active compound close to the
binding site.
Astemizole is a very lipophilic weak base with two
protonation sites (pKa1 5.6 and pKa2 8.5; Fischer et al.,
1997, 1998). Table I shows the calculated percentages
of the un-, mono-, and diprotonated forms of astemi-
zole at each of the evaluated pHs. Fig. 9 B shows that
after removal of astemizole from the bath, the hEag1
currents recover much slower at acidic pHint. This
washout had an average time constant of 25 s at pHint
8.4, and of 235 s at pHint 6.4 in our recording condi-
tions. This is consistent with the protonated forms of
astemizole being charged and membrane imperme-
able, and the unprotonated form being uncharged
and membrane permeable (Fischer et al., 1997). The
time course of block onset in Fig. 9 B was also slower at
pH 6.4 (60 s) than at 8.4 (20 s). This can be accounted
for by the time required to concentrate protonated
astemizole inside the cell.
Figure 9. pH dependence of astemizole block of
hEag1 channels. (A) Dose–response plots for astemizole
at pHext//pHint relations of 7.4//7.35 (open circles),
6.4//7.35 (closed inverted triangles), 8.4//7.35 (closed
upright triangles), 7.4//6.4 (open inverted triangles),
and 7.4//8.4 (open upright triangles). The steady-state
fraction of channels blocked was calculated as in Fig. 1
D. The data were ﬁtted using the Hill equation (solid
lines, see text for average IC50). Symbols and associated
error bars represent means   SEM for three (control
and pHext 8.4), ﬁve (pHext 6.4 and pHint 8.4), and ten
cells (pHint 6.4). (B) Time course of block onset and
washout in cells recorded with pHext 7.4 and pHint 6.4
(open inverted triangles) or 8.4 (open triangles). The
recording protocol consisted of a 1-s test pulse to 80 mV
applied every 30 s. The fraction of channels blocked was
calculated from the mean current recorded during the
last 20 ms of the test pulse. During the time indicated by
the solid line, cells were exposed to 250 nM (pHint 6.4)
or 5  M astemizole (pHint 8.4). Solid lines through
symbols represent the best ﬁt of single exponential
functions (see text for time constants) to the experimen-
tal data during drug application and washout. Symbols
and associated error bars represent means   SEM for
three cells tested in each condition. (C and D) logIC50
(C) and log(IC50)2 (D) plotted as a function of the pH
difference between pHext and pHint. Closed circles and
associated error bars represent means   SD of individual
ﬁts of cells shown in A. Straight line through symbols
represents the best ﬁt of linear functions with slopes and
y intercepts given in the text to the data. The dotted
lines have the same y intercepts, but slopes of  1. (E)
Superimposed hEag1 current recorded in the same
inside-out patch during 1-s depolarizations to 80 mV
from a holding potential of  70 mV in the absence
(top) or presence (bottom) of a 500 nM astemizole
concentration at the indicated bath pHs. Each current
trace presented is the average of three recordings at
each condition. (F) Inside-out current traces in the presence of astemizole were normalized dividing them point by point by the respective
preapplication traces. Traces shown represent the average current ratios from ﬁve patches recorded as in E.
TABLE I
Percentile Contribution of the Different Forms of Astemizole (pKa1   5.6 
and pKa2   8.5) at Different pH
pH
6.4 7.4 8.4
%%%
Unprotonateda 0.7 7.3 44.2
Monoprotonatedb 85.7 91.3 55.7
Diprotonatedc 13.6 1.4 0.1
a 100   [H ]2   den.
b 100   [H ]   Ka1   den.
c 100   Ka1   Ka2   den, where den   [H ]2   [H ]   Ka1   Ka1   Ka2
(Netter, 1969).311 García-Ferreiro et al.
These results suggest that the charged forms of
astemizole are more potent inhibitors of hEag1 chan-
nels than the neutral form. To avoid the complications
resulting from the change in total concentration of
internal astemizole by changes in the pHext//pHint
relation in whole-cell experiments, we directly ap-
plied astemizole to the intracellular side of inside-out
patches. A constant total astemizole concentration (500
nM) blocked more current at pHint of 6.4–7.4 than at
8.4 (Fig. 9 E). There was a positive correlation between
the change in the fraction of protonated drug (mono-
plus diprotonated), and the variation in the fractional,
isochronal block observed at the end of the pulse. A
40% decrease in total protonated astemizole from pHint
7.4 to 6.4 (Table I) correlates with a 44   13% (n   5)
decrease in the observed potency of block. On the
other hand, a 7% increase in total protonated astemi-
zole from pHint 7.4 to 6.4 (Table I) correlates with a 5  
4% increase in block (n   5).
The idea that both protonated forms of astemizole
are involved in the block of hEag1 channels is further
supported by the observation that the rate of block at
pHint 6.4 (6.7   2 s 1), is larger than at 7.4 (2.8   0.2
s 1; n   5; Fig. 2 F). At this pHint range, the predicted
monoprotonated concentration is expected to change
little (a decrease of 6%), but the diprotonated concen-
tration should increase almost 10-fold (Table I). Thus,
an interesting possibility is that the increase in the rate
of current block at pHint 6.4 reﬂects the increased par-
ticipation of the diprotonated form, with an increased
afﬁnity for the binding site. The ideal situation would
have been to compare the degree of block at pHint  
pKa1 and pHint    pKa2. Unfortunately, the inside-out
currents during a 100-mV depolarization were reduced
to  15% of their value at pHint 5.7, and complete but
reversibly disappeared with time in this solution
(unpublished data). We also analyzed whether a hypo-
thetical increase in the proportion of double-charged
astemizole could introduce voltage sensitivity to the
block by astemizole. However, in two cells without any
apparent run-down, analyzed at pHint 6.4 up to 160 mV
and at two concentrations of astemizole around the
IC50, no sign of voltage dependence of the effect could
be found (unpublished data).
Taken together, all results are consistent with the
idea that both imipramine and astemizole bind to
hEag1 channels in their charged forms from the intra-
cellular side. Fig. 10 A shows that the direct application
of a saturating dose of imipramine (25  M) at pH 6.0
(99.97% protonated) causes a complete current sup-
pression in inside-out patches, while it is less effective
in outside-out patches. Current inhibition in outside-
out patches ( 30%) can be accounted for by the  1
 M [imi ] inside the pipette (pH 7.4) predicted by Eq.
3. It should be noted that the permeation of imip-
ramine is an extremely fast process. The predicted
concentration of neutral imipramine in the bath, in
Fig. 10 B, is 7.5 nM neutral imipramine. This concen-
tration of neutral drug equilibrates with the pipette
solution surrounding the intracellular face of the chan-
nels with a time constant (182 ms) nearly indistinguish-
able from the time constant of direct block in inside-
out patches (155 ms). At external pH 7.4, the actions of
imipramine in inside-out and outside-out patches were
kinetically indistinguishable in our recording condi-
tions (unpublished data). This extremely fast rate of
membrane permeation of imipramine can account for
the fact that no evident reduction in the whole-cell cur-
Figure 10. Block of hEag1 channels by imip-
ramine, N-methyl-imipramine, and astemizole in cell-
free patches. (A and B) Successive 6-s recordings at
80 mV in the same inside-out (A) or outside-out
patches (B), respectively. At the time indicated by the
solid line, the substances where applied during 2.5 s
at the indicated concentrations. The bath solution
had, in both cases, a pH of 6.0, while the pipette
solution had a pH of 7.4. (C and D) Effect of appli-
cation of N-methyl-imipramine on representative
inside-out (C) and outside-out (D) patches, at both
external and internal pH of 7.4.312 Open-channel Block of hEag1 Channels
rent upon addition of 100  M imipramine to an intracel-
lular, pH 6.4 solution was observed (unpublished data).
To further characterize the sidedness of block by
imipramine, we synthesized the permanently charged,
quaternary derivative N-methyl-imipramine. When 5
 M N-methyl-imipramine was applied to the cytoplas-
mic side of inside-out patches, a rapid and completely
reversible inhibition of the current was observed (Fig.
10 C). However, the same concentration of this drug
had virtually no effect when applied to the extracellular
side in outside-out patches (Fig. 10 D). Assuming that
imipramine and N-methyl-imipramine share a common
site of action, these observations are incompatible with
the idea that imipramine acts from the extracellular
side (Kuo, 1998).
While the block induced by imipramine was fully re-
versed after 2-s washout during the depolarization to
100 mV in Fig. 10 A, hEag1 current did not recover
from astemizole block during the same period (Fig.
10 A, bottom). Full recovery did occur, however, in a
30-s interval at the holding potential between identical
pulses (unpublished data). The time constant for the
astemizole block in inside-out patches was 387 ms, 2.5
times that of imipramine. The 10 nM predicted con-
centration of neutral astemizole in Fig. 10 B equili-
brated with a time constant of 1.7 s. Therefore, the rate
of open channel block in the case of astemizole is not
rate limiting, and the 0.6 s 1 rate represents an esti-
mate of the equilibration process across the mem-
brane. The slow membrane permeation of astemizole
made it possible to induce a substantial block of whole-
cell currents when 25  M astemizole was added to a pH
6.4 intracellular solution (unpublished data).
DISCUSSION
We present here evidence that the charged forms of
imipramine and astemizole block the current through
hEag1 K  channels by binding to sites in the intracellu-
lar portion of the permeation pathway only accessible
when the channels are open. This mechanism of block
can be described using the model developed by Arm-
strong (1966, 1969, 1971) to explain the action of inter-
nal quaternary ammonium (QA) ions on the K  con-
ductance of squid giant axon, which has been subse-
quently applied to explain the effects of a number of
QA ions and protonated tertiary amines on different
K  channels (French and Shoukimas, 1981; Swenson,
1981; Choi et al., 1993; DeCoursey, 1995; Snyders and
Yeola, 1995; Horrigan and Gilly, 1996).
Even if their mechanism of block is similar, imip-
ramine and astemizole strongly differ in the afﬁnity,
kinetics, and voltage dependence of their interaction
with hEag1 channels. Comparing the state-dependent
interaction of both compounds with hEag1 renders in-
formation about the closed and open conformation of
these channels, as well as some unexpected pharma-
cokinetic characteristics of both drugs. Some differ-
ences between imipramine and astemizole in binding
to hEag1 are reminiscent of the difference between
TEA and QA compounds with longer alkyl side chains,
which show an increasing afﬁnity and decreasing disso-
ciation rate with increasing length of the alkyl side
chain (Choi et al., 1993). Thus, a ﬁrst conclusion is that
like the delayed rectiﬁer K  channel of squid axon and
Shaker K   channels, hEag1 channels seem to have an
auxiliary hydrophobic binding site in the intracellular
vestibule of the channel that accommodates the bulky
chain of astemizole. In the following paragraphs we will
consider the interaction of both compounds with
hEag1 separately.
Imipramine Binding to hEag1
Imipramine blocks several cardiac (Delpon et al., 1992;
Valenzuela et al., 1994) and neuronal (Ogata et al.,
1989; Wooltorton and Mathie, 1993, 1995; Kuo, 1998;
Cuellar-Quintero et al., 2001) voltage-gated and Ca2 -
activated K  channels (Dreixler et al., 2000; Terstappen
et al., 2001; Gavrilova-Ruch et al., 2002) as well as EGL-2
channels (Weinshenker et al., 1999), hERG channels
(Teschemacher et al., 1999), neuronal (Ogata et al.,
1989; Yang and Kuo, 2002) and cardiac (Ogata and
Narahashi, 1989; Habuchi et al., 1991) Na  channels,
and Ca2  channels (Ogata et al., 1989). There are some
differences in the afﬁnity with which imipramine inhib-
its these different ion channels, but in all cases the re-
ported IC50 values are in the  M range (1 to 30  M).
Moreover, in all cases, the dose–response curves are well
ﬁtted with a Hill coefﬁcient close to 1. The IC50 value we
report here for hEag1 (1.9  M at 80 mV) is in good
agreement with those published for the native Eag
currents in IGR1 melanoma cells (3.4  M at 50 mV;
Gavrilova-Ruch et al., 2002) and for cloned hERG chan-
nels (3.4  M at 20 mV; Teschemacher et al., 1999).
The fact that different ion channels show compara-
ble afﬁnities for imipramine suggests structural conser-
vation at the binding site across these very diverse ion
channel targets, and indicates that a similar mode of ac-
tion of imipramine could account for the inhibition of
all these channels (Wooltorton and Mathie, 1993). Un-
fortunately, only in few cases has the detailed mecha-
nism of action of imipramine been analyzed. Within
the K  channel family there is strong evidence that imi-
pramine blocks native A-type channels in atrial myo-
cytes (Delpon et al., 1992; Casis and Sanchez-Chap-
ula, 1998) and hippocampal neurons (Kuo, 1998) by
an open-channel block mechanism similar to that de-
scribed here for hEag1 channels. However, contrary to
our conclusions, Kuo (1998) suggests that imipramine
blocks channels in its uncharged form, and that the313 García-Ferreiro et al.
binding site is located at the extracellular side of the
channels. Wooltorton and Mathie (1993, 1995), who
analyzed the effects of several tricyclic compounds on
the K  current of rat sympathetic neurons, also pro-
posed the existence of an external binding site with a
high afﬁnity for the uncharged form of these com-
pounds.
Although our conclusions differ, there is no conﬂict
between the data shown in those studies and the data
presented here. Also we observe that (a) apparent af-
ﬁnity for tricyclic compounds (all weak bases with pKas
between 8.9 and 10; Wooltorton and Mathie, 1995) in-
creases with alkalinization of pHext and that (b) these
compounds do not show any obvious effect on the
whole-cell current when included in the pipette. How-
ever, we interpret (a) to result from an indirect in-
crease in the concentration of charged imipramine in-
side the cell, and (b) from the extremely high speed of
membrane permeation of this compound. This inter-
pretation is based on a number of accompanying ex-
perimental observations that are incompatible with an
uncharged blocker and an extracellular binding site,
and on measurements of a very fast rate of membrane
permeation for imipramine. In particular, we ﬁnd that
the block of imipramine is strongly voltage dependent
and estimate that imipramine passes 39% of the elec-
tric ﬁeld across the membrane before reaching its bind-
ing site for which it competes with intra- but not extra-
cellular TEA. Moreover, increasing the amount of pro-
tonated imipramine on the intracellular side of the
channels by variations of pHext and pHint in whole-cell
and inside-out patch recordings increases the block of
hEag1 currents by the precise amount predicted for im-
ipramine acting in its charged form. Finally, we synthe-
sized a quaternary derivative, permanently charged form
of imipramine, N-methyl-imipramine, and we show that
it blocks hEag1 channels in inside-out but not outside-
out patches.
Interestingly, all but one of the published previous
experimental observations can be explained assuming
that the binding site is intracellular and the charged
form is the active compound. Wooltorton and Mathie
(1995) reported that N-methyl-amitriptyline, a perma-
nently charged derivative of amitriptyline, does not in-
hibit the whole-cell K  current when included in the
patch pipette during whole-cell recordings. However, it
should be noted that permanently charged, quaternary
derivatives of open pore blockers can be as much as
100 times less potent than tertiary forms even if they
share the same site and mechanism of action (Kirsch
and Narahashi, 1983). Thus, taking into consideration
that 50  M amitriptyline blocked  90% of the current
(Wooltorton and Mathie, 1995), the single concentra-
tion of 50  M N-methylamitriptyline used by Wooltor-
ton and Mathie (1995) does not provide conclusive evi-
dence against an intracellular site of action. While we
cannot exclude that imipramine and other tricyclic
compounds block different ion channels by different
mechanisms, we propose that this class of drugs blocks
hEag1 and likely other K  channels by an open-pore
block acting from inside the cell.
What can we learn about hEag1 channels from their
interaction with imipramine? The voltage dependence
of imipramine binding and its competition with inter-
nal TEA argue that it binds close to the inner end of
the selectivity ﬁlter that is known to accommodate the
binding site for internal TEA of related KV channels
(Yellen et al., 1991; Choi et al., 1993). Interestingly the
fraction of the electric ﬁeld sensed by imipramine
(39%) is similar to that reported for Na  ions, which
also block Eag1 channels by an open-channel block
mechanism (45%; Pardo et al., 1998). Given that Na 
exclusion of the permeation pathway occurs directly at
the selectivity ﬁlter (Zhou et al., 2001), this suggests
that the protonation site in imipramine (a tertiary ni-
trogen) penetrates as far as this position. The access of
imipramine to this site requires hEag1 channels to
open. Thus opening of Eag channels must create a wid-
ening of its intracellular entryway that allows a com-
pound as large as imipramine to reach the inner end of
the selectivity ﬁlter. The reverse process constricts the
intracellular permeation pathway, making it too narrow
for imipramine, which has to unbind before the chan-
nel can close. Accordingly, no trapping of imipramine
in closed channels was observed. Eag channels are
structurally related to both KV and cyclic nucleotide
gated channels (Warmke et al., 1991; Warmke and
Ganetzky, 1994) that differ in the putative position of
their activation gate. While for KV channels it is sup-
posed to coincide with a bend in the distal part of the
S6 segment (Del Camino et al., 2000), cyclic nucleotide
gated channels have been suggested to switch to their
conducting state by a movement of the selectivity ﬁlter
itself (Flynn et al., 2001). The data presented here ar-
gue for a major rearrangement of the intracellular
opening of the channel during activation. Whether this
gate for imipramine also gates the access of the much
smaller K  ions remains to be investigated.
Amino acid residues located at the base of the pore
helix and along the S6 segment are determinants for
the binding of different compounds that block open
K  channels (for review see Decher et al., 2004). While
residues in S6 vary substantially between different K 
channels, the COOH-terminal end of the pore helices
just before the selectivity ﬁlter is highly conserved
(Mitcheson et al., 2000b). The ﬁrst of two positions are
occupied by a polar residue (either Ser or Thr) and the
next position is either Val or Ile (Mitcheson et al.,
2000b). It remains to be tested whether these residues
are important for the binding of tricyclic compounds.314 Open-channel Block of hEag1 Channels
Astemizole Binding Site
In contrast to imipramine, the actions of astemizole on
K  channels seem restricted to some members of the
eag family. For example, concentrations up to 10  M
astemizole have no signiﬁcant effects on the cardiac
IsK currents, IRK1 inward rectiﬁer K  channels, and
the voltage-gated K  channels Kv1.1 (Suessbrich et al.,
1996), Kv2.1, and Kv4.2 (unpublished data). Some
marginal effects of astemizole at high concentrations
have been reported for the outward currents of ventric-
ular cardiomyocytes (Berul and Morad, 1995). How-
ever, concentrations  10  M had no effects on these
currents. The Eag-like channels 2 (hELK2) are also not
sensitive to astemizole (Becchetti et al., 2002).
In contrast, HERG channels are highly sensitive to
astemizole (Suessbrich et al., 1996; Zhou et al., 1999).
This suggests structural conservation in the architec-
ture of HERG and hEag1 that supports the selective in-
hibition by this drug. A common feature of these chan-
nels is the lack of the Pro-X-Pro motif that is believed to
induce a sharp bend in the pore-lining S6 helices of
other voltage-gated K  channels (Del Camino et al.,
2000). This is supposed to confer a larger volume to
the inner cavity of HERG and hEag channels, as to
accommodate large molecules like astemizole (Mitch-
eson et al., 2000b). Instead of the Pro-X-Pro motif de-
scribed before, the corresponding sequence of HERG
and hEag channels reads Ile-Phe-Glu. The Phe at this
position (656 of HERG and 495 of hEag) has been
shown to be a major determinant for the particular sen-
sitivity of HERG channels to a large number of open
pore blockers (Mitcheson et al., 2000b; Chen et al.,
2002; Fernandez et al., 2004). Ficker et al. (2002) re-
port that mutation of Phe 656 to Cys dramatically re-
duces the afﬁnity of HERG channels to astemizole. It is
tempting to speculate that this conserved aromatic resi-
due might also be involved in the block of hEag1 chan-
nels by astemizole, which we have shown here to bind
in its charged form. The binding of a charged blocker
to an aromatic residue could occur through cation– 
interactions, which have been proposed to be a major
source of high afﬁnity drug–receptor interactions (for
review see Zacharias and Dougherty, 2002). Proximity
of the protonations sites in astemizole to Phe 656 of
hEag1 channels could also account for the lack of volt-
age sensitivity of the block by this drug. Note in Fig. 3
of Del Camino et al. (2000) that the sharp bend site in
KV channels is located at considerable distance from
the selectivity ﬁlter, where the major drop of electric
potential across the membrane takes place (MacKin-
non and Yellen, 1990; Yellen et al., 1991).
While the open states of both HERG and hEag
channels are similar in allowing the binding of rela-
tively large molecules in the permeation pathway, their
closed states seem to differ in this respect. Thus MK-
499, a charged organic compound of similar size and
structure as astemizole, is trapped in closed HERG
channels (Mitcheson et al. 2000a). In contrast to this,
we report here that both astemizole and the smaller im-
ipramine have to dissociate from hEag1 channels be-
fore they can close. This argues that the permeation
pathway, in particular the inner cavity that is supposed
to be the trapping site, is of smaller diameter in closed
hEag1 than in HERG channels. In conclusion, while
the open states of these related channels share pharma-
cological and therefore presumably structural features,
their closed states seem to differ substantially.
The reported IC50 for astemizole in cloned HERG is
0.9 nM (Zhou et al., 1999; but note that native rERG
currents in GH3 cells showed IC50 values in the range
of 50 nM; Barros et al., 1997), while that for hEag1 is
196 nM (Fig. 1) when both channels are expressed in
HEK-293 (human embryonic kidney) cells. Therefore,
some of the structural differences with HERG must ex-
plain the lower afﬁnity for the drug by hEag1. Gessner
et al. (2004) have shown that speciﬁc residue differ-
ences between hEag1 and hEag2 channels are critical
for the stabilization of various drugs in the pore of Eag
channels. However, these residues do not seem to be in-
volved in the block we describe here because hEag2
channels expressed in Xenopus oocytes were blocked
indistinguishable from hEag1 channels by astemizole
(IC50 for both  1.5  M; unpublished data). A major
difference between HERG and hEag1 kinetics is the
strong voltage-dependent inactivation of the ﬁrst ones.
Although it is still a matter of debate, inactivation has
been proposed to increase the sensitivity of HERG
channels to some substances (Suessbrich et al., 1997;
Zhang et al., 1999; Lees-Miller et al., 2000; Ficker et
al., 2001; but see Kiehn et al., 1996; Snyders and
Chaudhary, 1996; Thomas et al., 2002). In fact, it has
been proposed that aromates in the S6 segment reposi-
tion during activation/inactivation gating by means of
allosteric changes that take place during the process of
inactivation (Chen et al., 2002). This might account for
the higher afﬁnity of HERG channels for astemizole.
Possible Implications
The investigation of the physiological function of Eag1
channels has been largely precluded by the lack of se-
lective blockers (Bauer and Schwarz, 2001). Based on
the modulation of Eag activation kinetics by the resting
membrane potential and divalent cations (Terlau et
al., 1996), currents through endogenous Eag channels
have been identiﬁed in a number of preparations
(Meyer and Heinemann, 1998; Occhiodoro et al., 1998;
Meyer et al., 1999; Pardo et al., 1999; Ouadid-Ahidouch
et al., 2001; Gavrilova-Ruch et al., 2002). However, in
both the central and peripheral nervous system, it is
impossible to isolate currents through Eag channels315 García-Ferreiro et al.
based solely on these properties, due to the overwhelm-
ing presence of other K  currents. To elucidate the
function of these channels in the nervous system, as-
temizole might be a useful tool, as it appears to be spe-
ciﬁc for channels of the Eag family. HERG channels,
which are also blocked by this compound, can easily be
distinguished by their higher afﬁnity for the drug and
their distinctive biophysical properties.
In addition, Eag channels have been suggested to
promote the proliferation of cancer cells (Pardo et al.,
1999). It has recently been published that the exposure
of breast cancer cells to astemizole (Ouadid-Ahidouch
et al., 2001) and of melanoma cells to imipramine
(Gavrilova-Ruch et al., 2002) causes a signiﬁcant reduc-
tion in their proliferation rate. These effects have been
ascribed to an interaction of both drugs with Eag chan-
nels. Our observation that both imipramine and astem-
izole block Eag channels by occlusion of the perme-
ation pathway, which most likely entails no major allo-
steric changes, argues that ion permeation through the
channels is affecting cell cycle. Given the role of Eag
channels in cancer, the development of further speciﬁc
inhibitors of Eag channels as well as the investigation of
those described here might have considerable clinical
relevance (Catterall et al., 2002).
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